11 Jan 2019 Research

Leukaemia: Investigating stem cells to prevent cancer

What is this research looking at?

The development of effective treatments to prevent and eradicate leukaemia requires a better understanding of the mechanisms behind malignant (harmful) transformation and disease persistence during therapy.

Importantly, leukaemia development is associated with the acquisition of abnormal metabolic features, making cancer metabolism an attractive target for new therapeutic strategies.

Metabolism is closely associated to cell functions in normal and abnormal (malignant) tissues. By measuring metabolic heterogeneity in normal tissue (haemopoietic stem cells) and in cancer (leukaemia), I will determine whether distinct cell metabolic states are functionally connected to their potential for malignant transformation and therapy resistance.

I will test if malignant transformation and therapy resistance can be prevented or attenuated by targeting their metabolic dependencies. Results from the proposed research may lead to the development of new strategies for leukaemia eradication and prevention.

What could this mean for people with leukaemia?

This project investigates the metabolic features of stem cells in a bid to find out how to prevent them turning cancerous and to reduce resistance to treatment – this may lead to the development of new strategies for leukaemia eradication and prevention.

Related posts

A new clinical trial announced

21 May 2020

A new clinical trial announced

A study into the impact of severe covid-19 infection on patients who receive stem cell transplants for blood cancers and blood disorders.

Family ‘devastated’ by leukaemia after double diagnosis say ‘so much more needs to be done’

8 December 2023

Family ‘devastated’ by leukaemia after double diagnosis say ‘so much more needs to be done’

57-year-old Hampshire resident Karen Cracknell is supporting Leukaemia UK’s appeal for funds this Christmas, having experienced the ‘devastating impact’ after both her mother and father were diagnosed with blood cancer.  …

Statement from Leukaemia UK on the death of Her Majesty Queen Elizabeth II

8 September 2022

Statement from Leukaemia UK on the death of Her Majesty Queen Elizabeth II

On behalf of the Leukaemia UK team, Chair of Trustees, Chris Corbin OBE, has made the following statement: “We are extremely saddened to hear the news of the death of…

Leukaemia charities unite in Blood Cancer Awareness Month to improve diagnosis and the chances of survival

20 September 2021

Leukaemia charities unite in Blood Cancer Awareness Month to improve diagnosis and the chances of survival

Leading UK leukaemia charities Leukaemia Care and Leukaemia UK have announced a new collaboration to increase awareness of the signs and symptoms of leukaemia and drive improvements in the diagnosis of the disease. The campaign, Spot Leukaemia, is running throughout September – Blood Cancer Awareness Month.